FDA GOOD LAB PRACTICE PROPOSED REG REVISION ALLOWS PRODUCT CHARACTERIZATION AFTER INITIAL TOXICITY TESTS; CHANGES WOULD PROVIDE MORE FLEXIBILITY, FDA SAYS